NASDAQ: VERA - Vera Therapeutics, Inc.

Rentabilidade por seis meses: +9.31%
Setor: Healthcare

Cronograma de promoção Vera Therapeutics, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa

Vera Therapeutics, Inc., биотехнологическая компания клинической стадии, занимается разработкой и коммерциализацией лечения пациентов с серьезными иммунологическими заболеваниями. Его ведущим продуктом-кандидатом является атацицепт, гибридный белок, который вводится самостоятельно в виде подкожной инъекции, который находится в фазе IIb клинических испытаний для пациентов с нефропатией иммуноглобулина А; и для лечения волчаночного нефрита. Он также разрабатывает MAU868, моноклональное антитело для лечения инфекций, вызываемых виремией BK.

Mais detalhes
Ранее компания называлась Trucode Gene Repair, Inc. и сменила название на Vera Therapeutics, Inc. в апреле 2020 года. Vera Therapeutics, Inc. была зарегистрирована в 2016 году, ее штаб-квартира находится в Брисбене, Калифорния.

Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

EBITDA -0.011
EV/EBITDA 0.2776
Цена ао 41.93
P/BV 8.17
Сайт https://veratx.com
ISIN US92337R1014
Число акций ао 0.04271 млрд
Валюта usd
IPO date 2021-05-14
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Alteração de preço por dia: +1.41% (41.09)
Alteração de preço por semana: +7.04% (38.93)
Alteração de preço por mês: +4.72% (39.79)
Alteração de preço em 3 meses: +19.67% (34.82)
Mudança de preço em seis meses: +9.31% (38.12)
Mudança de preço por ano: +306.54% (10.25)
Mudança de preço em 3 anos: +155.64% (16.3)
Mudança de preço desde o início do ano: +208.67% (13.5)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 0 0
P/BV 6.71 1
P/E 0 0
EV/EBITDA -6.65 0
Total: 2.38

Eficiência

Nome Significado Nota
ROA, % -54.68 0
ROE, % -94.4 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0.7143 7.14
Total: 1.17

Obrigação

Nome Significado Nota
Debt/EBITDA -0.5036 10
Total: 8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 0 0
Rentabilidade Ebitda, % 824.69 10
Rentabilidade EPS, % -22.71 0
Total: 6
Mais detalhes

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Virtus LifeSci Biotech Clinical Trials ETF 0.90613 63.040315712071 0.33
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.10183 24.74842126706 1.59225
ProShares Ultra Nasdaq Biotechnology 0.14648 51.697637072723 0.85651
Dimensional US Core Equity Market ETF 0.00074 30.983243755928 1.40618
iShares ESG Aware MSCI USA Small-Cap ETF 0.05116 33.616398243045 1.49366
Fidelity MSCI Health Care Index ETF 0.02134 13.390080209527 1.46057
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05233 31.359936575053 1.41955
ProShares Hedge Replication ETF 0.00955 5.9237999659878 1.47892
Humankind US Stock ETF 0.01166 18.809430395549 1.99919
Invesco Nasdaq Biotechnology ETF 0.22131 28.578975171685 0.8565
iShares Morningstar Small-Cap ETF 0.03388 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.06755 33.628071953382 0.72598
iShares Russell 2000 Growth ETF 0.12375 38.042556988 0.6026
iShares Russell 3000 ETF 0.00309 32.57283798366 1.43482
iShares Morningstar Small-Cap ETF 0.03388 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.06755 680.05582339508 0.72598
Direxion Daily S&P Biotech Bull 3x Shares 0.41379 4067.9190751445 0.25924
Nuveen ESG Small-Cap ETF 0.14545 29.971671388102 1.41019
Schwab U.S. Small-Cap ETF 0.04859 34.281650071124 1.51433
Schwab U.S. Broad Market ETF 0.00318 32.5 1.43354
ProShares UltraPro Russell2000 0.03602 89.821266282945 1.47873
VictoryShares US Small Mid Cap Value Momentum ETF 0.14394 36.185892615431 1.97666
Vanguard U.S. Momentum Factor ETF 0.16 45.845704753962 1.05834
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.11 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0.05 35.648084105685 1.48801
Principal Healthcare Innovators ETF 0.22702 618.4964157054 0.8416
Future Tech ETF 0.22702 426.33969118983 0.8416



Supervisor Cargo Pagamento Ano de nascimento
Mr. Sean P. Grant M.B.A. Chief Financial Officer 585.5k 1985 (39 anos)
Mr. Joseph R. Young M.B.A. Senior VP of Finance & Chief Accounting Officer N/A 1973 (51 ano)
Mr. Julien E. Capers J.D. Senior Vice President of Legal N/A
Ms. Kelly Rauber Senior Vice President of Human Resources N/A
Mr. Tom Doan Senior Vice President of Development Operations N/A 1972 (52 ano)
Dr. Neeraj Pakala M.B.A., Ph.D. Senior VP and Head of Product Development & Manufacturing N/A
Dr. Kerry Cooper M.D. Senior Vice President of Medical Affairs N/A
Dr. Marshall W. Fordyce M.D. Founder, President, CEO & Director 1975 (49 anos)
Mr. David L. Johnson M.B.A. Chief Opearating Officer
Ms. Lauren Frenz M.B.A. Chief Business Officer 1985 (39 anos)

Endereço: United States, Brisbane. CA, 8000 Marina Boulevard - abrir no Google Maps, abrir mapas Yandex
Site: https://veratx.com